Temafloxacin-induced hemolytic anemia and renal failure.
School of Medicine, University of California Los Angeles, UCLA.
R L
RL
Deamer
J G
JG
Prichard
N
N
Koenker
R E
RE
James
D
D
Heming
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D004912:Erythrocytes / Q000276:immunology / Q000502:physiology; D005260:Female; D024841:Fluoroquinolones; D006461:Hemolysis; D006801:Humans; D007105:Immune Complex Diseases / Q000097:blood / Q000150:complications; D008875:Middle Aged; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C054745:temafloxacin